Rectal suppositories (candles) of Krasavka extract are indicated for hemorrhoids and anal fissures.
Composition
Active ingredient: 1 suppository contains thick belladonna extract (Belladonnae extractum spissum) in terms of the sum of alkaloids (1: 5) (extractant 20% (v/v) ethanol) 0.23 mg - 0.015 g;
Excipients: phenol, solid fat.
Contraindication
hypersensitivity to belladonna and other components of the drug. Cardiovascular diseases in which an increase in heart rate is undesirable: atrial fibrillation, tachycardia, chronic heart failure, ischemic heart disease, mitral stenosis, severe arterial hypertension. Glaucoma. Urinary retention or tendency to it. Myasthenia gravis. Gastrointestinal tract diseases accompanied by obstruction. Hyperthermic syndrome. Thyrotoxicosis. Acute bleeding.
Method of application
Used by adults. The suppository is removed from the packaging by cutting it with scissors along the contour of the suppository, and 1 suppository is injected deep into the rectum 2-3 times a day.
The duration of the course of treatment is determined by the doctor individually, taking into account the course and severity of the disease, the achieved therapeutic effect, and the general treatment tactics. The recommended duration of the course of treatment is 5-7 days.
Application features
Pregnant women
Not recommended for use.
Drivers
Given the possibility of side effects such as dizziness, you should refrain from driving or operating other machinery while using the drug.
Overdose
Symptoms: increased manifestations of adverse reactions, nausea, vomiting, tachycardia, decreased blood pressure, agitation, irritability, tremor, convulsions, insomnia, drowsiness, hallucinations, hyperthermia, depression of the central nervous system, depression of the activity of the respiratory and vascular centers.
Treatment: Gastric lavage, parenteral administration of cholinomimetics and anticholinesterase agents. Treatment is symptomatic.
Side effects
From the gastrointestinal tract: dry mouth, thirst, taste disturbances, dysphagia, decreased intestinal motility up to atony, decreased tone of the biliary tract and gallbladder. From the kidneys and urinary tract: difficulty and retention of urination. From the heart: palpitations, arrhythmia, including extrasystole, myocardial ischemia. From the blood vessels: facial flushing, feeling of hot flashes. From the nervous system: headache, dizziness. From the organs of vision: dilated pupils, photophobia, accommodation paralysis, increased intraocular pressure. From the respiratory system and mediastinal organs: decreased secretory activity and tone of the bronchi, which leads to the formation of viscous sputum, which is difficult to cough up. From the skin and subcutaneous tissue: skin rashes, urticaria, exfoliative dermatitis, hyperemia. Immune system disorders: anaphylactic reactions, anaphylactic shock.
Interaction
The effect of the drug may be enhanced by the simultaneous use of other drugs with antimuscarinic effects: M-holinoblockers, antiparkinsonian drugs (amantadine), antispasmodics, some antihistamines, butyrophenone drugs, phenothiazines, dispyramides, quinidine and tricyclic antidepressants, non-selective monoamine reuptake inhibitors.
Inhibition of peristalsis by atropine may alter the absorption of other drugs.
Storage conditions
Store in original packaging at a temperature not exceeding 15 °C.
Keep out of reach of children.
Shelf life - 2 years.
